Dr Mieke Van Hemelrijck explains the importance of define core outcome sets for prostate cancer

Bookmark and Share
Published: 13 May 2019
Views: 209
Rating:
Save
Dr Mieke Van Hemelrijck - Kings College London, Translational Oncology & Urology Research (TOUR)

PIONEER is a European Network of Excellence for Big Data in Prostate Cancer, consisting of 32 partners, including ecancer, across 9 countries. Our goal is to ensure the optimal care for all European men living with prostate cancer by unlocking the potential of Big Data and Big Data analytics.

Dr Mieke Van Hemelrijck explains her work in leading WP2 in PIONEER and discusses the importance of standardised outcome definitions.

For more information about the project, please visit the PIONEER website.

PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.